Once daily antibiotic regimen in paediatric oncology

Area of Science:

• Pediatric Oncology
• Infectious Diseases
• Pharmacology

Background:

• Febrile episodes are common in children undergoing cancer treatment.
• Prompt and effective antibiotic therapy is crucial for managing febrile neutropenia in pediatric cancer patients.
• Optimizing antibiotic regimens can improve treatment outcomes and reduce healthcare burdens.

Purpose of the Study:

• To evaluate the feasibility and efficacy of a once-daily antibiotic regimen for febrile episodes in pediatric cancer patients.
• To assess the success rate and safety of this simplified antibiotic dosing strategy.
• To determine if a once-daily regimen is a viable option for treating infections in immunocompromised children.

Main Methods:

• A retrospective analysis of 296 febrile episodes in children with malignant tumors over 44 months.
• Treatment involved a once-daily regimen of ceftriaxone-amikacin.
• Additional antibiotics (teicoplanin or vancomycin) were used for patients with central lines.

Main Results:

• The once-daily antibiotic regimen was successful in 272 out of 296 episodes (92%) without needing regimen changes.
• Only one patient experienced uncontrolled sepsis, highlighting the regimen's safety.
• The study demonstrated high efficacy and feasibility of the simplified dosing.

Conclusions:

• A once-daily antibiotic regimen is a feasible and effective strategy for managing febrile episodes in children with cancer.
• This approach simplifies treatment and maintains high success rates, making it a worthwhile option.
• The findings support the use of simplified antibiotic dosing in pediatric oncology to improve patient care.